-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2'-Deoxy-L-cytidine
Category | Hepatitis B Virus (HBV) |
CAS | 40093-94-5 |
Description | Torcitabine (2'-Deoxy-L-cytidine) is an antiviral agent. Torcitabine has the potential for chronic hepatitis B virus infection treatment. |
Product Information
Synonyms | 1-(2-Deoxy-b-L-erythro-pentofuranosyl)cytosine |
IUPAC Name | 4-amino-1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Molecular Weight | 227.22 |
Molecular Formula | C9H13N3O4 |
Canonical SMILES | C1C(C(OC1N2C=CC(=NC2=O)N)CO)O |
InChI | InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m1/s1 |
InChIKey | CKTSBUTUHBMZGZ-CHKWXVPMSA-N |
Boiling Point | 497.6°C at 760 mmHg |
Flash Point | 254.8°C |
Purity | ≥ 98% (HPLC) |
Density | 1.73 g/cm3 |
Solubility | In Vitro: H2O : 250 mg/mL (1100.26 mM; Need ultrasonic) DMSO : 250 mg/mL (1100.26 mM; Need ultrasonic) |
Appearance | White to off-white powder |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 355 |
Exact Mass | 227.09060590 |
Index Of Refraction | 1.719 |
In Vitro | Torcitabine (2'-Deoxy-L-cytidine) shows greater inhibition of first strand than second strand DNA synthesis. |
PSA | 110.60000 |
Target | HBV |
XLogP3-AA | -1.8 |